Medical News

RSS

Fewer doctors treating Medicare patients, CMS says

Amid payment rates and rules they dislike, more doctors are opting to not treat Medicare patients, say the Centers for Medicare & Medicaid Services. In the meantime, health care providers ready different models to change how Medicare pays doctors.

30 Jul 2013

Study: Decision aids result in improved prostate cancer knowledge

Both web-based and print-based decision aids appear to improve patients' informed decision making about prostate cancer screening up to 13 months later, but does not appear to affect actual screening rates, according to a study by Kathryn L. Taylor, Ph.D., of Georgetown University, Washington, D.C., and colleagues.

30 Jul 2013

Houston Methodist, Istanbul University Hospitals to collaborate on educational projects

Houston Methodist Global Health Care Services, the global subsidiary of Houston Methodist Hospital in Texas, USA, and Istanbul University Hospitals - General Directorate in Istanbul, Turkey, have signed a collaboration agreement in the areas of education and training.

30 Jul 2013

Glucose intolerance, insulin resistance not associated with pathological features of AD

Glucose intolerance or insulin resistance do not appear to be associated with pathological features of Alzheimer disease (AD) or detection of the accumulation of the brain protein β-amyloid (Αβ), according to a report published by JAMA Neurology, a JAMA Network publication.

30 Jul 2013

FDA approves Rebiotix's IND application to begin RBX2660 Phase 2 study for recurrent CDI

Rebiotix Inc. announced today that the U.S. Food and Drug Administration has approved the company's Investigational New Drug application to begin the Phase 2 clinical study of RBX2660 for the treatment of recurrent Clostridium difficile infection.

30 Jul 2013

Anacor Pharmaceuticals submits tavaborole NDA to FDA for treatment of onychomycosis

Anacor Pharmaceuticals announced today that on July 26, 2013 it submitted its New Drug Application to the U.S. Food and Drug Administration for tavaborole, its drug candidate for the topical treatment of onychomycosis. Onychomycosis is a fungal infection of the nail and nail bed that affects approximately 35 million people in the United States.

30 Jul 2013

National health and social care charity, Community Integrated Care, launches new five year strategy

National health and social care charity Community Integrated Care is proud to announce the launch of its new five year strategy, in which the organisation has committed to becoming ‘The UK’s Leading Health and Social Care Charity’.

From Community Integrated Care 29 Jul 2013

Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago

The USPSTF agreed with the CDC that since most patients (75%) who are currently infected with hepatitis C were born between 1945 - 1965, and since risk-based screening has not been successful in identifying these individuals, that a one time age-based hepatitis C blood test was necessary.

29 Jul 2013

First Edition: July 29, 2013

Today's headlines include reports about the White House's strategy for building support for the health law.

29 Jul 2013

Prana announces dosing of first patient in PBT2 Phase II trial for Alzheimer’s disease

Prana Biotechnology today announced that the first patient has been dosed in the 12-month open label extension study with Alzheimer’s Disease patients participating in Prana’s Phase 2 IMAGINE trial.

29 Jul 2013

Saudi and UK scientists provide detailed picture of MERS coronavirus

Saudi and UK scientists provide the most detailed picture yet of the clinical and laboratory characteristics of Middle East Respiratory Syndrome (MERS) coronavirus, revealing a wide range of clinical symptoms and an extremely high death rate among patients with co-existing medical conditions.

29 Jul 2013

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

Trovagene, Inc. (NASDAQ: TROV) and RainDance Technologies announced today that Trovagene has adopted RainDance's RainDropTM Digital PCR System for research and development, and for eventual use in the Trovagene CLIA laboratory.

29 Jul 2013

World Hepatitis Alliance calls for urgent action to address viral hepatitis

On World Hepatitis Day, the World Hepatitis Alliance has called for urgent attention to be given to recent figures showing that although viral hepatitis kills as many as HIV/AIDS, the great majority of countries have no programmes in place to tackle it.

29 Jul 2013

ALCF honors oncologist with Lectureship Award for ground-breaking work on lung cancer research

The Bonnie J. Addario Lung Cancer Foundation (ALCF) honored Tony Mok, MD, with the 2013 Addario Lectureship Award for his continued ground-breaking work for lung cancer patients, doctors and caregivers around the world. Dr. Mok, of Chinese University of Hong Kong, received the award at the 14th International Lung Cancer Congress held on July 25 in Huntington Beach, California.

29 Jul 2013

Hepatocytes from stem-cell derived human liver cells increase survival of animals with liver disease

Researchers have generated functional hepatocytes from human stem cells, transplanted them into mice with acute liver injury, and shown the ability of these stem-cell derived human liver cells to function normally and increase survival of the treated animals.

29 Jul 2013

CHMP gives positive opinion for approval of once-daily QVA149 for treatment of COPD

Sosei Group Corporation confirms the information released by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for approval of once-daily Ultibro® Breezhaler®, as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

29 Jul 2013

Researcher discovers potential explanation for shizophrenia symptoms

By observing the eye movements of schizophrenia patients while playing a simple video game, a University of British Columbia researcher has discovered a potential explanation for some of their symptoms, including difficulty with everyday tasks.

29 Jul 2013

Scientists identify key neurons that sense unexpected motion and have implications for motion sickness

It happens to all of us at least once each winter in Montreal. You're walking on the sidewalk and before you know it you are slipping on a patch of ice hidden under a dusting of snow.

29 Jul 2013

Study explores whether reducing smoke toxicant exposure affects biomarkers of biological effect

British American Tobacco has published the protocol for a clinical study designed to determine whether using reduced-toxicant prototype cigarettes that reduce smokers' exposure to smoke toxicants impacts biological effect (ISRCTN81286286).

29 Jul 2013

Young Swiss men understand risks of cannabis consumption

91 percent of on average 20-year-old Swiss men drink alcohol, almost half of whom drink six beverages or more in a row and are thus at-risk consumers. 44 percent of Swiss men smoke tobacco, the majority of whom are at-risk consumers - they smoke at least once a day. 36 percent of young adults smoke cannabis, whereby over half are at-risk consumers, using the drug at least twice a week.

29 Jul 2013

Medical News

Fewer doctors treating Medicare patients, CMS says

Study: Decision aids result in improved prostate cancer knowledge

Houston Methodist, Istanbul University Hospitals to collaborate on educational projects

Glucose intolerance, insulin resistance not associated with pathological features of AD

FDA approves Rebiotix's IND application to begin RBX2660 Phase 2 study for recurrent CDI

Anacor Pharmaceuticals submits tavaborole NDA to FDA for treatment of onychomycosis

National health and social care charity, Community Integrated Care, launches new five year strategy

Hepatitis C (HCV) testing for baby boomers: an interview with Dr. Donald Jensen, Director, Center for Liver Diseases, University of Chicago

First Edition: July 29, 2013

Prana announces dosing of first patient in PBT2 Phase II trial for Alzheimer’s disease

Saudi and UK scientists provide detailed picture of MERS coronavirus

Trovagene adopts RainDance's RainDrop digital PCR system for eventual use in CLIA laboratory

World Hepatitis Alliance calls for urgent action to address viral hepatitis

ALCF honors oncologist with Lectureship Award for ground-breaking work on lung cancer research

Hepatocytes from stem-cell derived human liver cells increase survival of animals with liver disease

CHMP gives positive opinion for approval of once-daily QVA149 for treatment of COPD

Researcher discovers potential explanation for shizophrenia symptoms

Scientists identify key neurons that sense unexpected motion and have implications for motion sickness

Study explores whether reducing smoke toxicant exposure affects biomarkers of biological effect

Young Swiss men understand risks of cannabis consumption

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News